Gene therapy group awards $1.3 million for research in glioblastoma, sarcoma, and ovarian cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nori Kasahara

Seth Pollack

Daniel Powell

Three scientists received $1.3 million in funding from the Alliance for Cancer Gene Therapy, the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer. These grants will be used to study immunotherapy and virotherapy in the treatment of glioblastoma, sarcoma and ovarian cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Growing up in inner-city Detroit, Otis Brawley had a thriving community made up of his parents, Jesuit priests, friends, and neighbors encouraging him that he could do anything he put his mind to. 
On Feb. 3, the House of Representatives passed the Senate Amendment to H.R. 7148, the Consolidated Appropriations Act, 2026, by a vote of 217 to 214. Later that day, President Donald Trump signed the bill into law, officially ending the brief partial government shutdown that began on Jan. 31. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login